Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Survival Analysis01:21

Cancer Survival Analysis

343
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
343
Statistical Methods for Analyzing Epidemiological Data01:25

Statistical Methods for Analyzing Epidemiological Data

353
Epidemiological data primarily involves information on specific populations' occurrence, distribution, and determinants of health and diseases. This data is crucial for understanding disease patterns and impacts, aiding public health decision-making and disease prevention strategies. The analysis of epidemiological data employs various statistical methods to interpret health-related data effectively. Here are some commonly used methods:
353
Kaplan-Meier Approach01:24

Kaplan-Meier Approach

129
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
129
Actuarial Approach01:20

Actuarial Approach

74
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
74
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

177
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
177

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evaluating risk prediction models: the Predictiveness curve and its geometric summaries.

American journal of epidemiology·2026
Same author

Reduced hypopharyngeal muscle strength in patients with dysphagia symptoms after anterior cervical discectomy and fusion.

Perioperative medicine (London, England)·2026
Same author

Age-related differences in outcomes and tumor characteristics of ultra-rare sarcomas: A Nation-wide Study.

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology·2026
Same author

Association of Cancer Care Quality Certification With Survival Across Multiple Cancer Types: A Population-Based Cohort Study in Taiwan.

International journal of cancer·2026
Same author

Explainable artificial intelligence for personalized prognosis in pancreatic cancer: A nationwide study from Taiwan.

PLOS digital health·2026
Same author

Second primary malignancies in Asian chronic lymphocytic leukaemia patients: A Taiwan Cancer Registry Study.

British journal of haematology·2026

Related Experiment Video

Updated: Jun 25, 2025

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

250

Predicting Lung Cancer Survival to the Future: Population-Based Cancer Survival Modeling Study.

Fan-Tsui Meng1,2, Jing-Rong Jhuang3, Yan-Teng Peng2

  • 1Institute of Epidemiology and Preventive Medicine, College of Public Health, National Taiwan University, Taipei, Taiwan.

JMIR Public Health and Surveillance
|May 31, 2024
PubMed
Summary

Lung cancer survival rates in Taiwan are improving, with predictions showing a 38.7% 5-year survival rate by 2020. This progress suggests the Lung Ambition Alliance

Keywords:
early diagnosislow-dose computed tomographylung cancerlung cancer screeningpopulation healthpopulation-basedpredictionprognosispublic healthsurveillancesurvivalsurvival trendsurvivorship-period-cohort model

More Related Videos

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.1K
Pre-Conditioning the Airways of Mice with Bleomycin Increases the Efficiency of Orthotopic Lung Cancer Cell Engraftment
09:02

Pre-Conditioning the Airways of Mice with Bleomycin Increases the Efficiency of Orthotopic Lung Cancer Cell Engraftment

Published on: June 28, 2018

13.6K

Related Experiment Videos

Last Updated: Jun 25, 2025

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

250
Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.1K
Pre-Conditioning the Airways of Mice with Bleomycin Increases the Efficiency of Orthotopic Lung Cancer Cell Engraftment
09:02

Pre-Conditioning the Airways of Mice with Bleomycin Increases the Efficiency of Orthotopic Lung Cancer Cell Engraftment

Published on: June 28, 2018

13.6K

Area of Science:

  • Oncology and Public Health
  • Epidemiological Modeling

Background:

  • Lung cancer is a leading global cause of cancer mortality.
  • Late diagnosis significantly impacts patient prognosis and survival rates.
  • The Lung Ambition Alliance aims to double the 5-year lung cancer survival rate by 2025.

Purpose of the Study:

  • To assess the feasibility of the Lung Ambition Alliance's goal in Taiwan.
  • To predict future lung cancer survival rates using a survivorship-period-cohort model.
  • To analyze trends in lung cancer survival within the Taiwanese population.

Main Methods:

  • Retrospective analysis of 205,104 lung cancer patients (1997-2018).
  • Application of the survivorship-period-cohort model to calculate survival rates.
  • Extrapolation of 1-year interval survival data to predict 5-year outcomes for diagnoses up to 2020.

Main Results:

  • Predicted 5-year survival rate for 2020 reached 38.7%, up from 23.8% in 2013.
  • Significant survival improvements observed starting in 2004.
  • Varied survival improvements noted across different demographics and histological types.

Conclusions:

  • Lung cancer survival rates in Taiwan have notably improved.
  • Improvements are attributed to low-dose computed tomography screening, advanced diagnostics, and treatments.
  • The Lung Ambition Alliance's goal appears achievable with continued advancements in medical technology and health policies.